Aortic Valve Market Size - Trends & Opportunities by 2025


Posted May 11, 2018 by nishthavohra

The different types of valves available in the aortic valve market are transcatheter valves, sutureless valves and others. Among these, transcatheter valves attained the largest share of 58.8% in the market, in 2017.

 
The different types of valves available in the aortic valve market are transcatheter valves, sutureless valves and others. Among these, transcatheter valves attained the largest share of 58.8% in the market, in 2017. This leading position of the category is attributed to increasing initiatives for research activities for developing transcatheter valves and increasing number of clinical trials to study transcatheter valves.

[b]Explore Report At: https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample[/b]

On the basis of type of surgery, aortic valve market is segmented into MIS and open surgery. The adoption of these valves for MISs is expected to grow at a faster CAGR of 13.7% during the forecast period.

The key end user in the aortic valve market includes hospitals, and others. Among these, hospitals registered the larger share, of 76.3%, in the market in 2017, owing to increasing number of patient population with valvular diseases in the hospitals.

During the forecast period, the aortic valve industry is expected to witness the fastest growth in demand in Asia-Pacific (APAC), at a CAGR of 13.0%, owing to the presence of large number of patient population with cardiovascular diseases, rising number of aortic valve replacement surgeries, growing medical tourism, and continuously improving healthcare infrastructure.

Globally, key players in the aortic valve industry are seeking for approvals to launch new products in the market. For instance, in February 2018, Edwards Lifesciences Corporation received CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open surgery.

In March 2018, LivaNova Plc received CE Mark approval for its Bicarbon aortic valves for use with low-dose anticoagulant therapy. This expanded indication of the company’s Bicarbon family of mechanical valves is based on evidence and results from the LOWERING-IT trial.

Some of the other key players operating in the aortic valve market are Medtronic plc and Boston Scientific Corporation.

[b]Download Free Sample Report At: https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample[/b]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By P&S Market Research Report
Phone 1-888-778-7886
Country United States
Categories Biotech , Business , Research
Tags aortic , aortic valve , aortic valve market , life science , market research , medical , medical device , research report
Last Updated May 11, 2018